103997-21-3 Usage
Uses
Used in Pharmaceutical Industry:
5-Chloro-6-oxo-1,6-dihydropyridine-2-carboxylic acid is used as a precursor in the synthesis of calcium channel blockers for the treatment of conditions such as high blood pressure and angina. Its role in the production of these drugs is crucial due to its ability to contribute to the development of effective medications that help manage cardiovascular health.
Used in Cardiovascular Disease Research:
5-Chloro-6-oxo-1,6-dihydropyridine-2-carboxylic acid is used as a research compound for studying its potential therapeutic effects in cardiovascular diseases. Its chemical properties and structure make it a promising candidate for the development of new treatments and therapies that can improve cardiovascular health and address related conditions.
Used in Neurodegenerative Disorder Research:
In addition to its applications in cardiovascular research, 5-Chloro-6-oxo-1,6-dihydropyridine-2-carboxylic acid has also been studied for its potential therapeutic effects in neurodegenerative disorders. Its unique chemical properties allow researchers to explore its potential in developing treatments that can help manage or alleviate the symptoms of these conditions.
Used in Medicinal Chemistry:
5-Chloro-6-oxo-1,6-dihydropyridine-2-carboxylic acid is used as a starting material in the synthesis of various bioactive compounds in medicinal chemistry. Its versatile chemical structure enables the development of new compounds with potential therapeutic applications, contributing to the advancement of pharmaceutical research and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 103997-21-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,9,9 and 7 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 103997-21:
(8*1)+(7*0)+(6*3)+(5*9)+(4*9)+(3*7)+(2*2)+(1*1)=133
133 % 10 = 3
So 103997-21-3 is a valid CAS Registry Number.
103997-21-3Relevant academic research and scientific papers
Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor
Ando, Makoto,Sato, Nagaaki,Nagase, Tsuyoshi,Nagai, Keita,Ishikawa, Shiho,Takahashi, Hirobumi,Ohtake, Norikazu,Ito, Junko,Hirayama, Mioko,Mitobe, Yuko,Iwaasa, Hisashi,Gomori, Akira,Matsushita, Hiroko,Tadano, Kiyoshi,Fujino, Naoko,Tanaka, Sachiko,Ohe, Tomoyuki,Ishihara, Akane,Kanatani, Akio,Fukami, Takehiro
experimental part, p. 6106 - 6122 (2009/12/24)
A series of 2-pyridone-containing imidazoline derivatives was synthesized and evaluated as neuropeptide Y Y5 receptor antagonists. Optimization of the 2-pyridone structure on the 2-position of the imidazoline ring led to identification of 1-(difluoromethy
